|
1
|
Anti-GD2 antibody with GM-CSF, interleukin-2, and isotretinoin for neuroblastoma.
|
N Engl J Med
|
2010
|
6.34
|
|
2
|
Long-term results for children with high-risk neuroblastoma treated on a randomized trial of myeloablative therapy followed by 13-cis-retinoic acid: a children's oncology group study.
|
J Clin Oncol
|
2009
|
5.12
|
|
3
|
Purged versus non-purged peripheral blood stem-cell transplantation for high-risk neuroblastoma (COG A3973): a randomised phase 3 trial.
|
Lancet Oncol
|
2013
|
2.25
|
|
4
|
Retinoid therapy of high-risk neuroblastoma.
|
Cancer Lett
|
2003
|
1.97
|
|
5
|
Phase I trial of oral fenretinide in children with high-risk solid tumors: a report from the Children's Oncology Group (CCG 09709).
|
J Clin Oncol
|
2006
|
1.43
|
|
6
|
Clinical significance of tumor-associated inflammatory cells in metastatic neuroblastoma.
|
J Clin Oncol
|
2012
|
1.37
|
|
7
|
Phase I dose escalation of iodine-131-metaiodobenzylguanidine with myeloablative chemotherapy and autologous stem-cell transplantation in refractory neuroblastoma: a new approaches to Neuroblastoma Therapy Consortium Study.
|
J Clin Oncol
|
2006
|
1.25
|
|
8
|
Semiquantitative mIBG scoring as a prognostic indicator in patients with stage 4 neuroblastoma: a report from the Children's oncology group.
|
J Nucl Med
|
2013
|
1.25
|
|
9
|
Iodine-131--metaiodobenzylguanidine double infusion with autologous stem-cell rescue for neuroblastoma: a new approaches to neuroblastoma therapy phase I study.
|
J Clin Oncol
|
2009
|
1.11
|
|
10
|
Treatment of primary CNS germinomatous germ cell tumors with chemotherapy prior to reduced dose whole ventricular and local boost irradiation.
|
Pediatr Blood Cancer
|
2010
|
1.05
|
|
11
|
Phase I trial of oral irinotecan and temozolomide for children with relapsed high-risk neuroblastoma: a new approach to neuroblastoma therapy consortium study.
|
J Clin Oncol
|
2009
|
1.03
|
|
12
|
Phase I trial of fenretinide delivered orally in a novel organized lipid complex in patients with relapsed/refractory neuroblastoma: a report from the New Approaches to Neuroblastoma Therapy (NANT) consortium.
|
Pediatr Blood Cancer
|
2013
|
1.03
|
|
13
|
Comparison of iodine-123 metaiodobenzylguanidine (MIBG) scan and [18F]fluorodeoxyglucose positron emission tomography to evaluate response after iodine-131 MIBG therapy for relapsed neuroblastoma.
|
J Clin Oncol
|
2009
|
1.00
|
|
14
|
Approaches to treatment for extraocular retinoblastoma: Children's Hospital Los Angeles experience.
|
J Pediatr Hematol Oncol
|
2004
|
0.98
|
|
15
|
Phase I study of vincristine, irinotecan, and ¹³¹I-metaiodobenzylguanidine for patients with relapsed or refractory neuroblastoma: a new approaches to neuroblastoma therapy trial.
|
Clin Cancer Res
|
2012
|
0.97
|
|
16
|
Outcome of high-risk stage 3 neuroblastoma with myeloablative therapy and 13-cis-retinoic acid: a report from the Children's Oncology Group.
|
Pediatr Blood Cancer
|
2009
|
0.94
|
|
17
|
A phase I study of zoledronic acid and low-dose cyclophosphamide in recurrent/refractory neuroblastoma: a new approaches to neuroblastoma therapy (NANT) study.
|
Pediatr Blood Cancer
|
2010
|
0.92
|
|
18
|
Dose escalation study of no-carrier-added 131I-metaiodobenzylguanidine for relapsed or refractory neuroblastoma: new approaches to neuroblastoma therapy consortium trial.
|
J Nucl Med
|
2012
|
0.88
|
|
19
|
Phase I trial of lestaurtinib for children with refractory neuroblastoma: a new approaches to neuroblastoma therapy consortium study.
|
Cancer Chemother Pharmacol
|
2011
|
0.86
|
|
20
|
Phase 1 study of concurrent RMP-7 and carboplatin with radiotherapy for children with newly diagnosed brainstem gliomas.
|
Cancer
|
2005
|
0.85
|
|
21
|
Peripheral blood stem cell support for multiple cycles of dose intensive induction therapy is feasible with little risk of tumor contamination in advanced stage neuroblastoma: a report from the Childrens Oncology Group.
|
Pediatr Blood Cancer
|
2010
|
0.85
|
|
22
|
A Phase I study of concurrent RMP-7 and carboplatin with radiation therapy for children with newly diagnosed brainstem gliomas.
|
Cancer
|
2005
|
0.85
|
|
23
|
Thyroid and hepatic function after high-dose 131 I-metaiodobenzylguanidine (131 I-MIBG) therapy for neuroblastoma.
|
Pediatr Blood Cancer
|
2010
|
0.84
|
|
24
|
Choroid plexus tumors; management, outcome, and association with the Li-Fraumeni syndrome: the Children's Hospital Los Angeles (CHLA) experience, 1991-2010.
|
Pediatr Blood Cancer
|
2011
|
0.81
|
|
25
|
Probable fatal drug interaction between intravenous fenretinide, ceftriaxone, and acetaminophen: a case report from a New Approaches to Neuroblastoma (NANT) Phase I study.
|
BMC Res Notes
|
2014
|
0.77
|
|
26
|
Successful multimodality therapy of recurrent multifocal juvenile granulosa cell tumor of the ovary.
|
J Pediatr Hematol Oncol
|
2002
|
0.76
|
|
27
|
The significance of serial histopathology in a residual mass for outcome of intermediate risk stage 3 neuroblastoma.
|
Pediatr Blood Cancer
|
2012
|
0.75
|